NASDAQ · CERT
Certara, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CERT: Nov 05, 2026
Certara, Inc. Common Stock is expected to report earnings on 11/05/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.05. The reported EPS for the same quarter last year was $0.09.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.05 | $0.06 | $0.04 | 2 |
| Dec 2026 | $0.07 | $0.08 | $0.06 | 2 |
| Mar 2027 | $0.06 | $0.07 | $0.06 | 2 |
| Jun 2027 | $0.09 | $0.11 | $0.06 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · MarketBeat · Zacks · RTTNews- The Motley Fool · Aug 4, 10:12 PM EDTCertara (CERT) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 4, 10:04 AM EDTCertara Q2 Earnings Call Highlights3 Momentum Stocks That Could Soar Post-Market VolatilityCertara (NASDAQ:CERT) reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue outlook while outlining
- Zacks · Aug 4, 8:50 AM EDTCertara, Inc. (CERT) Q2 Earnings and Revenues Lag EstimatesCertara (CERT) delivered earnings and revenue surprises of -20.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 3, 5:47 AM EDTCertara Q2 Earnings Preview: Can Software Revenue Help Sustain Growth?(RTTNews) – Certara Inc. (CERT) is scheduled to report second-quarter 2026 financial results before the market opens on August 4, 2026. The company will host a conference call at 8:30 a.m. ET to discuss the results.
- RTTNews · Jun 18, 1:34 AM EDTCertara Names Faiz Mohammed As Interim CFO As Gallagher Resigns(RTTNews) – Certara, Inc. (CERT), a commercial-stage drug development services company, announced on Wednesday that current Chief Financial Officer, John Gallagher, will resign on July 14, 2026.
- RTTNews · Jun 16, 11:02 PM EDTTop Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212(RTTNews) – Tuesday's top gainers include CervoMed, with key clinical trial catalysts ahead; Conexeu, which strengthened its leadership with board expansion; NeOnc, advancing its lead drug candidate into Phase 2 for aggressive brain tumours; and Simulations Plus, which is set to
- MarketBeat · Jun 7, 2:02 PM EDTCertara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference3 Momentum Stocks That Could Soar Post-Market VolatilityCertara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly appointed
- The Motley Fool · May 11, 1:32 PM EDTCertara (CERT) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · May 11, 10:07 AM EDTCertara Q1 Earnings Call Highlights3 Momentum Stocks That Could Soar Post-Market VolatilityCertara (NASDAQ:CERT) reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a strategic reset under
- Zacks · May 11, 7:45 AM EDTCertara, Inc. (CERT) Q1 Earnings Miss EstimatesCertara (CERT) delivered earnings and revenue surprises of -20.57% and +1.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 5:55 PM EDTVoyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue EstimatesVoyager Therapeutics (VYGR) delivered earnings and revenue surprises of +12.96% and -74.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Mar 20, 9:05 AM EDTProtagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?Protagonist Therapeutics (PTGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Certara, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.